Adocia

Adocia is a clinical-stage biotechnology company specializing in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its preclinical pipeline includes three products: BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1.